ADMA Biologics (ADMA) Short Interest Ratio & Short Volume → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free ADMA Stock Alerts $6.82 +0.01 (+0.15%) (As of 08:49 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ADMA Biologics Short Interest DataCurrent Short Volume8,110,000 sharesPrevious Short Volume7,290,000 sharesChange Vs. Previous Month+11.25%Dollar Volume Sold Short$48.50 millionShort Interest Ratio / Days to Cover3.2Last Record DateApril 15, 2024Outstanding Shares228,220,000 sharesPercentage of Shares Shorted3.55%Today's Trading Volume8,545 sharesAverage Trading Volume2,566,194 sharesToday's Volume Vs. Average0% Short Selling ADMA Biologics ? Sign up to receive the latest short interest report for ADMA Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatADMA Short Interest Over TimeADMA Days to Cover Over TimeADMA Percentage of Float Shorted Over Time Ad American Hartford Gold GroupRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE ADMA Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,110,000 shares $48.50 million +11.3%N/A3.2 $5.98 3/31/20247,290,000 shares $48.11 million -8.8%N/A2.7 $6.60 3/15/20247,990,000 shares $47.86 million +18.9%N/A3 $5.99 2/29/20246,720,000 shares $36.02 million +9.3%N/A2.6 $5.36 2/15/20246,150,000 shares $33.21 million -10.1%N/A2.9 $5.40 1/31/20246,840,000 shares $35.50 million -14.8%N/A3.2 $5.19 Get the Latest News and Ratings for ADMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADMA Biologics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,030,000 shares $40.07 million +19.0%N/A3.7 $4.99 12/31/20236,750,000 shares $30.51 million -13.6%N/A3.4 $4.52 12/15/20237,810,000 shares $32.80 million -10.2%N/A4.2 $4.20 11/30/20238,700,000 shares $32.19 million -6.3%N/A4.9 $3.70 11/15/20239,280,000 shares $35.26 million -3.1%N/A4.8 $3.80 10/31/20239,580,000 shares $32.38 million +3.9%N/A4.1 $3.38 10/15/20239,220,000 shares $29.60 million +3.3%N/A4.2 $3.21 9/30/20238,930,000 shares $31.97 million +2.8%N/A4.1 $3.58 9/15/20238,690,000 shares $32.41 million -1.9%N/A4.1 $3.73 8/31/20238,860,000 shares $34.11 million -1.7%N/A4 $3.85 8/15/20239,010,000 shares $40.91 million +8.4%N/A4.2 $4.54 7/31/20238,310,000 shares $34.49 million -2.4%N/A4.1 $4.15 7/15/20238,510,000 shares $30.38 million +2.7%N/A4.2 $3.57 6/30/20238,290,000 shares $30.59 million -19.8%N/A3.9 $3.69 6/15/202310,340,000 shares $41.26 million -1.2%N/A4.6 $3.99 5/31/202310,460,000 shares $42.57 million -6.4%N/A4.4 $4.07 5/15/202311,170,000 shares $46.80 million -1.2%N/A4.6 $4.19 4/30/202311,310,000 shares $37.89 million -2.8%N/A5.1 $3.35 4/15/202311,640,000 shares $37.02 million -6.8%N/A4.9 $3.18 3/31/202312,490,000 shares $41.34 million +14.4%N/A5.1 $3.31 3/15/202310,920,000 shares $34.18 million +0.8%N/A4.4 $3.13 2/28/202310,830,000 shares $38.45 million -6.2%N/A3.8 $3.55 2/15/202311,550,000 shares $41.35 million -9.7%N/A3.9 $3.58 1/31/202312,790,000 shares $47.20 million +6.1%N/A3.8 $3.69 1/15/202312,050,000 shares $40.97 million -5.3%N/A3.7 $3.40 12/30/202212,720,000 shares $49.35 million +1.8%N/A4 $3.88 12/15/202212,500,000 shares $44.50 million -37.4%N/A3.7 $3.56 11/30/202219,980,000 shares $66.73 million -8.1%N/A6 $3.34 11/15/202221,740,000 shares $70.44 million -15.9%N/A7.2 $3.24 10/31/202225,860,000 shares $72.93 million +0.2%N/A9.1 $2.82 10/15/202225,820,000 shares $67.65 million -6.3%N/A9.5 $2.62 9/30/202227,560,000 shares $66.97 million +6.0%N/A10.4 $2.43 9/15/202225,990,000 shares $70.43 million -2.0%N/A9 $2.71 8/31/202226,520,000 shares $71.60 million -6.2%N/A9.8 $2.70Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning (Ad)Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE ADMA Short Interest - Frequently Asked Questions What is ADMA Biologics' current short interest? Short interest is the volume of ADMA Biologics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 8,110,000 shares of ADMA short. Learn More on ADMA Biologics' current short interest. What is a good short interest ratio for ADMA Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ADMA shares currently have a short interest ratio of 3.0. Learn More on ADMA Biologics's short interest ratio. Which institutional investors are shorting ADMA Biologics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ADMA Biologics: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is ADMA Biologics' short interest increasing or decreasing? ADMA Biologics saw a increase in short interest in April. As of April 15th, there was short interest totaling 8,110,000 shares, an increase of 11.2% from the previous total of 7,290,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ADMA Biologics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to ADMA Biologics: Neumora Therapeutics, Inc. (11.07%), Inhibrx, Inc. (6.18%), Beam Therapeutics Inc. (16.00%), 4D Molecular Therapeutics, Inc. (19.21%), Twist Bioscience Co. (21.19%), Cullinan Oncology, Inc. (6.38%), Fusion Pharmaceuticals Inc. (5.73%), Scholar Rock Holding Co. (15.91%), Recursion Pharmaceuticals, Inc. (26.39%), Tarsus Pharmaceuticals, Inc. (20.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ADMA Biologics stock? Short selling ADMA is an investing strategy that aims to generate trading profit from ADMA Biologics as its price is falling. ADMA shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ADMA Biologics? A short squeeze for ADMA Biologics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ADMA, which in turn drives the price of the stock up even further. How often is ADMA Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ADMA, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NMRA Short Squeeze INBX Short Squeeze BEAM Short Squeeze FDMT Short Squeeze TWST Short Squeeze CGEM Short Squeeze FUSN Short Squeeze SRRK Short Squeeze RXRX Short Squeeze TARS Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ADMA) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersCould Your Accounts Be Frozen?Allegiance GoldElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry